Osterweis Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Sell
97,320
-51,626
-35% -$5.61M 0.69% 48
2026
Q1
$13.8M Buy
148,946
+13,010
+10% +$1.31M 0.71% 47
2025
Q4
$13.9M Sell
135,936
-79,075
-37% -$7.07M 0.59% 47
2025
Q3
$13.4M Sell
215,011
-25,305
-11% -$1.38M 0.61% 47
2025
Q2
$12.5M Sell
240,316
-56,255
-19% -$2.51M 0.6% 48
2025
Q1
$12.6M Buy
+296,571
New +$12.8M 0.62% 53
2021
Q1
Sell
-39,850
Closed -$5.14M 139
2020
Q4
$5.14M Buy
39,850
+16,230
+69% +$1.87M 0.31% 82
2020
Q3
$2.64M Buy
+23,620
New +$2.16M 0.18% 91
2020
Q2
Sell
-45,220
Closed -$3.15M 118
2020
Q1
$3.15M Buy
45,220
+10,690
+31% +$820K 0.26% 72
2019
Q4
$2.7M Buy
+34,530
New +$2.49M 0.19% 79

Other funds holding GH

Osterweis Capital Management's GH Position: Q2 2026 in Review

Osterweis Capital Management reduced its Guardant Health (GH) stake by 35% in Q2 2026, selling an estimated $5.61M and leaving 97,320 shares worth $14.6M. The position accounts for 0.69% of the portfolio, ranked #48.

Osterweis Capital Management first reported a position in GH in Q4 2019 and has held it in 10 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Osterweis Capital Management held 97,320 shares of Guardant Health worth $14.6M as of Q2 2026.
  • Osterweis Capital Management sold 51,626 Guardant Health shares in Q2 2026, an estimated $5.61M.
  • Guardant Health made up 0.69% of Osterweis Capital Management's portfolio in Q2 2026, its #48 holding.
  • Osterweis Capital Management first reported a position in Guardant Health in Q4 2019 and has held it in 10 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Osterweis Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.